CANF

Can-Fite BioPharma Ltd.

6 catalysts on file

CANF

Can-Fite BioPharma Ltd.

Catalyst AI-extracted

Namodenoson

decompensated liver cirrhosis

148d ago Mar 26, 2026

SEC 6-K verified 2mo ago

Countdown card →

CANF

Can-Fite BioPharma Ltd.

Approval AI-extracted

Namodenoson

hepatocellular carcinoma

147d ago Mar 27, 2026

SEC 6-K verified 2mo ago

Countdown card →

CANF

Can-Fite BioPharma Ltd.

Phase 2 Confirmed

Namodenoson

pancreatic cancer

113d ago Apr 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

CANF

Can-Fite BioPharma Ltd.

Phase 3 AI-extracted

Namodenoson

hepatocellular carcinoma

52d ago Jun 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

CANF

Can-Fite BioPharma Ltd.

Phase 2 AI-extracted

Piclidenoson

Lowe Syndrome

T-minus 40 days ~ Sep 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

CANF

Can-Fite BioPharma Ltd.

Phase 3 Confirmed

Piclidenoson

psoriasis

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →